Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
about
A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United StaStreptococcus pneumoniae Cell-Wall-Localized Phosphoenolpyruvate Protein Phosphotransferase Can Function as an Adhesin: Identification of Its Host Target Molecules and Evaluation of Its Potential as a VaccineThe prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, KenyaEffect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--Alaska, 2008-2012.Parapneumonic empyema deaths during past century, Utah.Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USAMolecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyemaVaccine escape recombinants emerge after pneumococcal vaccination in the United States.Survey of childhood empyema in Asia: implications for detecting the unmeasured burden of culture-negative bacterial disease.Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study.Antimicrobial resistance among isolates causing invasive pneumococcal disease before and after licensure of heptavalent conjugate pneumococcal vaccineRealtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive diseaseAntimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah.Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse model.Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccineMonitoring the long-term molecular epidemiology of the pneumococcus and detection of potential 'vaccine escape' strains.Streptococcus pneumoniae clonal complex 199: genetic diversity and tissue-specific virulenceSafety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology.Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era.Serotype replacement in disease after pneumococcal vaccinationDetection and serotyping of Streptococcus pneumoniae from nasopharyngeal samples by PCR-based multiplex assay.Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete.Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies.Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types.Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.Initial effects of the National PCV7 Childhood Immunization Program on adult invasive pneumococcal disease in Israel.Streptococcus pneumoniae serotype 6C: an intra- and interclonal complex comparison.Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era.Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine.The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.Serotype competence and penicillin resistance in Streptococcus pneumoniaeBiochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae Serotype 20 strains: discovery of a new pneumococcal serotypePneumococcal serotypes associated with invasive disease in under five children in India & implications for vaccine policy.Incidence of and risk factors for community acquired pneumonia in US HIV-infected children, 2000-2005.The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi district, Kenya.Nasopharyngeal colonization: a target for pneumococcal vaccination.
P2860
Q28085452-F13B3147-BC13-4A01-AED3-3FE4C5F2B493Q28550871-F0DA4CF3-16E7-4F12-88AD-31560183023BQ28731923-F1D508EA-4C52-4418-8D6D-E86430D80A92Q30218803-AE4E69C4-DBD1-4DD6-B8B0-78FB6BC08EC3Q30374152-C25EED94-8DF8-4F2B-8F5C-FFF4DAE5B23FQ30412578-10D36C3A-11DC-48EA-98BF-1CFB24BC977AQ30498477-54306718-8A45-49B4-8D7C-1BD8DFCDA8CDQ33306103-ABEFDC27-69A7-470B-8EB4-8093F300DF97Q33351058-2B32643F-EC79-4FE9-8C60-CCBE12BCB757Q33371823-0A112326-7EB3-45BA-9B46-7A838823E7DEQ33470299-8840F948-1F78-4395-951E-CF182BF7DFE4Q33533300-75B5B0AE-AF46-4284-BC17-207E395853EAQ33571285-F268FEDD-C3F7-4A0E-83E4-9B6C5A1C2A8AQ33627308-79C0F765-0303-4732-9E3B-55B60B4B596FQ33653107-E3DD7A64-8C48-4E5E-9645-63C9C636DF04Q33724436-49FBD554-2F0E-45EC-98CF-D8F65C09C429Q33777082-307D50BC-7CB0-432B-827B-3C014B717994Q33802910-920380F1-3E04-4D6D-8CAC-9DC32F717081Q33886611-5B9E62FD-442C-4EB0-B9D5-2CEE22512DD6Q33909172-A7AC3546-C4D7-4A7D-BEE3-8F63B4FC8D6AQ33947633-5302B361-0288-41C4-9584-F4B25C3C31CDQ34157622-BA925DAD-AA96-4891-9541-5BC895512CE3Q34178363-103E46E9-F4D3-4F20-8FF4-706FD66BAB1BQ34231633-F1E124A4-9522-4A01-9B00-C87B05FE4BC0Q34235508-5FBB6866-84D9-477B-BDE8-AA7D637D9C3DQ34395856-7E807A5F-0BE9-49D1-A439-EF53735C7D69Q34681065-7E7C3D8A-FE11-4DA8-9B42-354D6100E7F9Q34774773-D97307B6-1C89-4AD9-B3FA-071ACF3A2B4FQ35004396-822D7C6B-D66E-4C07-A182-7287C07F9E9BQ35091736-F3A7ACA3-0470-47B0-B014-DD2618B3E3D5Q35096385-30CD48E0-8DA1-4231-9E77-FAB283B83898Q35619069-F7464CBE-230F-4EDF-B66A-4E8B55D0EAA5Q35785952-22F4ECDD-FB66-4CF4-AAE9-78CAC00E61F1Q35822877-F25CE8E5-2C5A-4F70-A96B-496ED9147347Q36023589-177A3A42-0CCF-49E5-9191-9C95D9D00989Q36201961-890DDC5F-380B-4C65-9D60-546A3A5A81B9Q36347414-07211D9C-693C-4046-9B24-131C0E43969CQ36622946-537F2D8C-8791-4DB3-86D8-FBC766385438Q36655717-E1D75F23-4ED9-47DE-8A10-187618ADE569Q36689018-5DB34CE1-6EF3-4D29-8F8A-5DA59390B70C
P2860
Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Temporal trends of invasive di ...... ence of nonvaccine serogroups.
@en
Temporal trends of invasive di ...... ence of nonvaccine serogroups.
@nl
type
label
Temporal trends of invasive di ...... ence of nonvaccine serogroups.
@en
Temporal trends of invasive di ...... ence of nonvaccine serogroups.
@nl
prefLabel
Temporal trends of invasive di ...... ence of nonvaccine serogroups.
@en
Temporal trends of invasive di ...... ence of nonvaccine serogroups.
@nl
P2093
P2860
P356
P1476
Temporal trends of invasive di ...... ence of nonvaccine serogroups.
@en
P2093
Andrew T Pavia
Cheryl K Shutt
David Glover
Edward O Mason
Gregory J Stoddard
Jasmin Jensen
Kent Korgenski
Matthew H Samore
Sean Firth
P2860
P356
10.1086/430604
P407
P577
2005-05-26T00:00:00Z